Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 1/20 | 0.60 |
| ▸ | ACP3 | P15309 | 5/20 | 0.50 |
| ▸ | ANPEP | P15144 | 4/20 | 0.50 |
| ▸ | LAP3 | P28838 | 3/20 | 0.50 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.47 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.47 |
| ▸ | DPP4 | P27487 | 2/20 | 0.46 |
| ▸ | F2 | P00734 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Amino(Phenyl)Methylphosphonic Acid SCHEMBL233491 | 1.00 | SRC (0.60) | SRCACP3ANPEPLAP3ERAP1 | |
| Amino(Phenyl)Methylphosphonic Acid SCHEMBL7647462 | 1.00 | SRC (0.60) | SRCACP3ANPEPLAP3ERAP1 | |
| Amino(Phenyl)Methylphosphonic Acid SCHEMBL5575088 | 0.98 | SRC (0.58) | SRCACP3ANPEPLAP3ERAP1 | |
| Amino(Phenyl)Methylphosphonic Acid SCHEMBL11121764 | 0.84 | CA2 (0.48) | SRCACP3ANPEPLAP3ERAP1 | |
| SCHEMBL11034382 | 0.82 | SRC (0.50) | SRCACP3ANPEPLAP3DPP4 | |
| Amino(Phenyl)Methylphosphonic Acid SCHEMBL30161941 | 0.81 | SRC (0.42) | SRCACP3ANPEPLAP3DPP4 | |
| SCHEMBL15397888 | 0.79 | ANPEP (0.44) | SRCACP3ANPEPLAP3ERAP2 | |
| Aminodiphenylmethane SCHEMBL1764332 | 0.78 | SRC (0.56) | SRCACP3ANPEPLAP3DPP4 | |
| Hydrochloric Acid SCHEMBL5935336 | 0.77 | CA12 (0.44) | SRCACP3 | |
| SCHEMBL11497064 | 0.77 | CYP1A2 (0.55) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1345918-B1 | 1,5 BENZOTHIAZEPINES AND THEIR USE AS ANTIHYPERLIPIDEMICS | ASTRAZENECA AB (SE) | 2007-04-18 | — | — | EP | disclosed |
| US-7192945-B2 | Benzothiazepine derivatives | ASTRAZENECA AB (SE) | 2007-03-20 | — | — | US | disclosed |
| US-20040067933-A1 | Chemical compounds | ELOBIX AB (SE) | 2004-04-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040067933-A1 | Chemical compounds | SLC10A2, SLC10A1, ABCB11 | SRC 1541/4885ACP3 1785/4885ANPEP 2516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.